View in EDS

Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).

Saved in:
Bibliographic Details
Title: Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Authors: Mullol J; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain., Han JK; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA., Laidlaw TM; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hopkins C; Department of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK., Peters AT; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany., Desrosiers M; Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada., Lee SE; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lane AP; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Chen C; Biometrics, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Chon Y; Global Biostatistical Science, Amgen, Thousand Oaks, California, USA., Ponnarambil SS; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Foster A; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Lindsley AW; US Medical Affairs, Amgen, Thousand Oaks, California, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Source: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2026 May; Vol. 16 (5), pp. 534-536. Date of Electronic Publication: 2026 Apr 17.
Publication Type: Letter
Journal Info: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41995120
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mullol+J%22">Mullol J</searchLink>; Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Han+JK%22">Han JK</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Laidlaw+TM%22">Laidlaw TM</searchLink>; Division of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hopkins+C%22">Hopkins C</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Peters+AT%22">Peters AT</searchLink>; Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pfaar+O%22">Pfaar O</searchLink>; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Desrosiers+M%22">Desrosiers M</searchLink>; Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+SE%22">Lee SE</searchLink>; Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lane+AP%22">Lane AP</searchLink>; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Biometrics, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chon+Y%22">Chon Y</searchLink>; Global Biostatistical Science, Amgen, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Ponnarambil+SS%22">Ponnarambil SS</searchLink>; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Foster+A%22">Foster A</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lindsley+AW%22">Lindsley AW</searchLink>; US Medical Affairs, Amgen, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101550261%22">International forum of allergy & rhinology</searchLink> [Int Forum Allergy Rhinol] 2026 May; Vol. 16 (5), pp. 534-536. <i>Date of Electronic Publication: </i>2026 Apr 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+for+ARS-AAOA+by+Wiley-Blackwell%22">Published for ARS-AAOA by Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101550261 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2042-6984 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220426976%22">20426976 </searchLink><i>NLM ISO Abbreviation: </i>Int Forum Allergy Rhinol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41995120
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/alr.70168
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 534
    Titles:
      – TitleFull: Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mullol J
      – PersonEntity:
          Name:
            NameFull: Han JK
      – PersonEntity:
          Name:
            NameFull: Laidlaw TM
      – PersonEntity:
          Name:
            NameFull: Hopkins C
      – PersonEntity:
          Name:
            NameFull: Peters AT
      – PersonEntity:
          Name:
            NameFull: Pfaar O
      – PersonEntity:
          Name:
            NameFull: Desrosiers M
      – PersonEntity:
          Name:
            NameFull: Lee SE
      – PersonEntity:
          Name:
            NameFull: Lane AP
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Chon Y
      – PersonEntity:
          Name:
            NameFull: Ponnarambil SS
      – PersonEntity:
          Name:
            NameFull: Foster A
      – PersonEntity:
          Name:
            NameFull: Lindsley AW
      – PersonEntity:
          Name:
            NameFull: Ambrose CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2042-6984
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International forum of allergy & rhinology
              Type: main
ResultId 1